GSK1360707F

GSK1360707F
Systematic (IUPAC) name
	(1R,6S)-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-4-azabicyclo[4.1.0]heptane
Clinical data
Pregnancy cat.	?
Legal status	?
Identifiers
ATC code	?
PubChem	CID 24802841
Chemical data
Formula	C14H17Cl2NO
Mol. mass	286.196 g/mol
	SMILES COCC13CC1(CCNC3)c(cc2Cl)ccc2Cl;
(what is this?) (verify);

GSK1360707F is a new and potent selective triple reuptake inhibitor.^[1]^[2]

This research chemical is still relatively new so no details are available for it yet.

[edit] Synthesis

^ Micheli, F.; Cavanni, P.; Andreotti, D.; Arban, R.; Benedetti, R.; Bertani, B.; Bettati, M.; Bettelini, L. et al. (2010). "6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor". Journal of Medicinal Chemistry 53 (13): 4989–5001. doi:10.1021/jm100481d. PMID 20527970. |displayauthors= suggested (help) edit
^ Deschamps, N. M.; Elitzin, V. I.; Liu, B.; Mitchell, M. B.; Sharp, M. J.; Tabet, E. A. (2010). "An Enyne Cycloisomerization Approach to the Triple Reuptake Inhibitor GSK1360707F". The Journal of Organic Chemistry 76 (2): 101221161656011. doi:10.1021/jo102098y. PMID 21174473. edit